BHPP1-S — Peptide Research Compound

Catalog ID: BHPP1-S | CAS: 910463-68-2 | Sequence: AcNH-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-Arg-Arg-Ala-Ala-Ala-Ala-Gly-Glu-OH (GLP-1 analog)

Compound Overview

BHPP1-S is a synthetic analog of Glucagon-Like Peptide-1 (GLP-1), designed for receptor pharmacology, metabolic signaling, and peptide kinetics research.
It is a long-acting GLP-1 receptor agonist with sequence modifications enhancing stability and receptor selectivity.
For laboratory research only — not for human consumption or therapeutic use.

Molecular Characteristics

• Synonyms:  BHPP1-S (7–37) analog; Modified incretin peptide
• CAS Number: 910463-68-2
• Sequence: Modified GLP-1 receptor agonist peptide analog
• Molecular Formula: C₁₈₇H₂₉₁N₄₅O₅₉
• Molecular Weight: ≈ 4113.6 g/mol
• Purity: ≥ 98% (HPLC)
• Formulation: Lyophilized peptide powder

Physical Properties

• Appearance: White to off-white lyophilized powder
• Solubility: BAC water or 0.6 % acetic acid (for research use only)
• Container: Sterile sealed vial

Storage & Stability

• Unreconstituted: Store at −20 °C, protected from light and moisture.
• Reconstituted: Aliquot and store at −20 °C; avoid repeated freeze–thaw cycles.

Research Context

BHPP1-S is used in in vitro and in vivo models to investigate GLP-1 receptor binding affinity, cAMP-dependent signal transduction, and metabolic receptor cross-talk.
It is a reference compound for studying incretin signaling, glucose regulation, and peptide pharmacodynamics in laboratory-based endocrine research.